Why is India Glycols Ltd falling/rising?

Recent Price Movement and Market Context

India Glycols Ltd’s stock closed at ₹1,002.10, down by ₹4.25 or 0.42% as of 08:47 PM on 06-Jan. This decline continues a short-term downward trend, with the stock falling for four consecutive days and registering a year-to-date loss of 1.65%. The intraday low touched ₹984.85, marking a 2.14% dip during the session. Despite this, the stock remains well above its 100-day and 200-day moving averages, signalling that the longer-term technical outlook remains intact. However, it is trading below its 5-day, 20-day, and 50-day moving averages, indicating some near-term weakness.

Investor participation has notably increased, with delivery volumes rising by 18.74% on 05 Jan compared to the five-day average, suggesting heightened trading activity amid the recent price decline. Liquidity remains sufficient for sizeable trades, with the stock’s average traded value supporting transactions of approximately ₹0.25 crore.

Strong Earnings and Market Outperformance

India Glycols has demonstrated robust earnings growth in recent quarters, with profit after tax (PAT) for the latest six months reaching ₹138.31 crore, reflecting a growth rate of 25.63%. The company’s return on capital employed (ROCE) for the half-year period stands at a healthy 11.46%, its highest level, while the debtors turnover ratio has also improved to 30.92 times, indicating efficient receivables management.

These positive financial metrics have contributed to the stock’s impressive long-term performance. Over the past year, India Glycols has delivered a remarkable 60.08% return, significantly outperforming the Sensex’s 9.10% gain. Its three-year and five-year returns of 167.69% and 501.86% respectively, further underscore its market-beating credentials. This sustained outperformance has attracted investor interest, even as the stock faces short-term selling pressure.

Underlying Concerns and Valuation Challenges

Despite recent successes, the company’s long-term fundamentals present some challenges. The average ROCE over a longer horizon is a modest 8.55%, reflecting moderate capital efficiency. Growth in net sales has been relatively subdued, expanding at an annual rate of 7.92% over the past five years, while operating profit has grown at 16.92% annually. These figures suggest that while profitability has improved, top-line growth remains limited.

Additionally, the company’s ability to service debt is a concern, with a high Debt to EBITDA ratio of 3.21 times, indicating leverage risks that may weigh on investor sentiment. Valuation metrics also point to a mixed picture; the stock’s ROCE of 10.2 and an enterprise value to capital employed ratio of 2 suggest a relatively expensive valuation. Although the stock trades at a discount compared to peers’ historical averages, its price-earnings-to-growth (PEG) ratio of 1.1 implies that current price levels already factor in much of the anticipated profit growth.

Balancing Short-Term Weakness Against Long-Term Strength

The recent decline in India Glycols’ share price appears to be a reflection of short-term profit-taking and technical corrections rather than a fundamental breakdown. The stock’s performance remains broadly in line with its sector, and its liquidity and rising investor participation suggest that the market is actively reassessing its valuation. While the company’s recent quarterly results have been encouraging, concerns over slower long-term sales growth and elevated debt levels temper enthusiasm.

Investors should weigh the company’s strong earnings momentum and market-beating returns against its valuation and leverage risks. The stock’s current pullback may offer an opportunity for those confident in its growth trajectory, but caution is warranted given the mixed signals from its financial metrics and recent price action.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →